His study verifies that silencing of CCL19 reduces tumor cell proliferation and suppresses invasion and migration, suggesting that the CCL19/CCR7 axis may mediate the pathogenesis of human prostate tumor [18]. The gene discussed is CCR7; the disease is neoplasm.